Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Details)

v3.24.3
Stockholders' Equity (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Dec. 22, 2023
Nov. 23, 2023
Oct. 23, 2023
Sep. 27, 2023
Aug. 18, 2023
Jul. 26, 2023
Jul. 19, 2023
Jun. 22, 2023
Jun. 16, 2023
Jun. 15, 2023
Jun. 05, 2023
Jun. 01, 2023
May 24, 2023
Jan. 26, 2023
Sep. 28, 2023
Dec. 31, 2023
Dec. 31, 2022
Stockholders’ Equity [Line Items]                                  
Convertible preferred shares                               45,000,000 45,000,000
Stock issued during period, restricted shares   778         956                    
Stock issued during period shares 20,520   17,000                       94,056    
Stock issued value in lieu of settlement of accounts payable (in Dollars) $ 35,088   $ 37,571                         $ 188,804 $ 151,874
Per share fair value (in Dollars per share) $ 1.71     $ 2.85                 $ 3.9        
Common stock purchase agreement (in Dollars)                             $ 311,220 $ 572,906 725,050
Warrants issued to purchase of common stock                   54,872              
Warrants exercise price (in Dollars per share)                   $ 9.75              
Subscription payable (in Dollars)                     $ 600,000            
Unvested stock options and restricted stock awards (in Dollars)                                 $ 220,000
Common Stock [Member]                                  
Stockholders’ Equity [Line Items]                                  
Stock issued during period, restricted shares                 14,445         756   16,935 7,400
Stock issued during period shares       7,910 8,734 4,837   3,264   15,238     6,807     69,072 11,651
Stock issued value in lieu of settlement of accounts payable (in Dollars)       $ 22,542 $ 32,750 $ 16,686   $ 17,621         $ 26,545     $ 69 $ 12
Per share fair value (in Dollars per share)     $ 2.21   $ 3.75 $ 3.45   $ 5.4                  
Aggregate shares of common stock                     129,458            
Common Stock Purchase Agreement [Member]                                  
Stockholders’ Equity [Line Items]                                  
Stock issued during period shares               200,000       200,000          
Common stock purchase agreement (in Dollars)               $ 134,634       $ 127,053          
Minimum [Member]                                  
Stockholders’ Equity [Line Items]                                  
Reverse split                               1  
Warrants exercise price (in Dollars per share)                               $ 1.43  
Maximum [Member]                                  
Stockholders’ Equity [Line Items]                                  
Reverse split                               15  
Warrants exercise price (in Dollars per share)                               $ 1.573  
Series A Convertible Preferred Stock [Member]                                  
Stockholders’ Equity [Line Items]                                  
Authorized shares                               900,000 900,000
Authorized per share (in Dollars per share)                               $ 0.001 $ 0.001